Skip to main content
Premium Trial:

Request an Annual Quote

Microarrays Take a Closer Look at Cancer Genetics

At the University of Pennsylvania, genome researchers have created a method for analyzing concordant genomic aberrations for determining important regions for tumor progression, according to a paper in PLoS Genetics. Using a method called Multiple Sample Analysis, they used microarrays to create profiles of conserved aberrations in certain cancer types, allowing them to validate targets for cancer therapies.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.